Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous wound bupivacaine infusion versus intravenous morphine PCA after thoracic and lumbar spinal fixation surgery
IRCT20100127003213N7Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine and morphine in postoperative pain (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started Nov 2019; status: completed.
02
Drugs
bupivacainemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20100127003213N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003213N7.